Savaria Co. (TSE:SIS – Get Free Report) Director Jean-Louis Chapdelaine sold 25,000 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of C$27.73, for a total transaction of C$693,250.00. Following the sale, the director directly owned 100,000 shares in the company, valued at C$2,773,000. This represents a 20.00% decrease in their ownership of the stock.
Savaria Price Performance
Shares of Savaria stock opened at C$27.99 on Friday. The company has a current ratio of 1.71, a quick ratio of 0.91 and a debt-to-equity ratio of 31.42. The stock has a market capitalization of C$2.01 billion, a price-to-earnings ratio of 25.45, a P/E/G ratio of 42.72 and a beta of 0.97. Savaria Co. has a 1-year low of C$18.71 and a 1-year high of C$30.62. The firm’s 50-day moving average price is C$27.61 and its two-hundred day moving average price is C$24.80.
Savaria (TSE:SIS – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported C$0.31 EPS for the quarter. The company had revenue of C$235.55 million for the quarter. Savaria had a return on equity of 12.41% and a net margin of 8.50%. On average, equities analysts predict that Savaria Co. will post 1.2048518 earnings per share for the current fiscal year.
Analyst Ratings Changes
Check Out Our Latest Stock Report on SIS
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Recommended Stories
- Five stocks we like better than Savaria
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
